Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
NEJM 365:1284-1292,1338, Kimberlin, D.W.,et al, 2011
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011
Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011
Warfarin-Related Intraventricular Hemorrhage
Neurol 77:1840-1846, Biffi, A.,et al, 2011
Diagnosis and Treatment of Psychogenic Parkinsonism
JNNP 82:1300-1303, Jankovic, J., 2011
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Relationship Between Chronic Atrial Fibrillation and Worse Outcomes in Stroke Patients After Intravenous Thrombolysis
Arch Neurol 68:1454-1458, Seet, R.C.S.,et al, 2011
Acutely Injured Patients on Dabigatran
NEJM 365:2039-2040, Cotton, B.A.,et al, 2011
Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011
Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011
Diagnosis and Management of Sports-Related Concussion a 15-Year-Old Athlete With a Concussion
JAMA 306:79-86, Zafonte, R., 2011
Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011
Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011
Spontaneous Regression of an Intracerebral Lymphoma (ghost tumor) in a Liver-Engrafted Patient
The Neurologist 17:218-221, Korner, S.,et al, 2011
Cerebral Venous Sinus Thrombosis Associated with Cerebral Hemorrhage Is Anticoagulant Treatment Safe?
The Neurologist 17:208-210, Fuentes, B.,et al, 2011
Trigger Factors and Their Attributable Risk for Rupture of Intracranial Aneurysms A Case-Crossover Study
Stroke 42:1878-1882, Vlak, M.H.M.,et al, 2011
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011
Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011
What Is the Current Status of Invasive Treatment of Extracranial Carotid Artery Disease?
Stroke 42:2080-2085, Naylor, A.R., 2011
Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011
Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011
Treatment of Unruptured Cerebral Aneurysms: Cause for Concern?
AJNR 32:1076-77, Molyneux, A.J., 2011
Patient Outcomes are Better for Unruptured Cerebral Aneurysms Treated at Centers that Preferentially Treat with Endovascular Coiling: A Study of the National Inpatient Sample 2001-2007
AJNR 32:1065-1070, 1076, Brinjiikii, W.,et al, 2011
Movement Disorders Emergencies Part 2 Hyperkinetic Disorders
Arch Neurol 68:719-724, Robottom, B.J.,et al, 2011
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Lancet 377:2013-2022, Bousser, M.G.,et al, 2011
Are subjects with spondylotic cervical cord encroachment at increased risk of cervical spinal cord injury after minor trauma?
JNNP 82:779-781, Benarik, J.et al, 2011
Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
Arch Neurol 68:899-904, Weintraub, D.,et al, 2011
Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss
JAMA 305(20):2071-2079,2114, Rauch, S.D.,et al, 2011
Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011
Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011
Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011
Reliability of Prehospital Real-Time Cellular Video Phone in Assessing the Simplified National Institutes of Health Stroke Scale in Patients With Acute Stroke
Stroke 42:1522-1527, Gonzalez, M.A.,et al, 2011
5 Versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study
Lancet 377:1837-1845,1809, Molyneux, E.,et al, 2011
Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011
Neurocryptococcoma: Curative Treatment with Surgical and Medical Modalities and 9 Year Follow up
Pro UCLA Healthcare 14:1-6, Romanova, M.I., 2011
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011
Promising New Procedure Offers Hope for Patients with Intracerebral Hemorrhage
JAMA 306:255-256, Mitka, M., 2011
Neurological disturbances caused by intravascular lymphomatosis
Brain Nerve 63:443-449, Mizutani, T., 2011
Contemporary management and recent advances in paediatric hydrocephalus
BMJ 343:d4191, Kandasamy, J.,et al, 2011
Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011
Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011
Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011
Impact of Obesity on Stroke Outcome After Intravenous Thrombolysis
Stroke 42:2330-2332, Sarikaya, H.,et al, 2011
Efficacy of Intravenous Tissue-Type Plasminogen Activator in Central Retinal Artery Occlusion Report From a Randomized, Controlled Trial
Stroke 42:2229-2234, Chen, C.S.,et al, 2011
Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis
Neurol 77:341-348, Strbian, D.,et al, 2011
Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011